Imagine if doctors could determine, many years in advance, who is likely to develop dementia. Such prognostic capabilities would give patients and their families time to plan and manage treatment and care. Thanks to artificial intelligence research conducted at McGill University, this kind of predictive power could soon be available to clinicians everywhere.

Classified as: Amyloid, Artificial intelligence, Dr. Pedro Rosa-Neto, dementia, Alzheimer's disease
Category:
Published on: 22 Aug 2017

For years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheimer's disease (AD). Which one is the driving force behind dementia? The answer: both of them, according to a new study by researchers at the Douglas Mental Health University Institute.

Classified as: McGill University, faculty of medicine, Douglas Mental Health University Institute, science and technology, Alzheimer's disease (AD), Dr. Pedro Rosa-Neto, neuroproject
Category:
Published on: 20 Apr 2016
Back to top